FR901228 in Treating Patients With Metastatic Breast Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well FR901228 works in treating patients with metastatic
breast cancer. Drugs used in chemotherapy, such as FR901228, work in different ways to stop
the growth of tumor cells, either by killing the cells or by stopping them from dividing.
FR901228 may also stop the growth of tumor cells by blocking some of the enzymes needed for
cell growth